WCN'22 Nephrology Annual Review Course

Recorded On: 02/24/2022

Back to Package

The course comprises three sessions on current issues in nephrology: Advances in Glomerulonephritis therapy, lessons learned from COVID-19, and an overview of chronic kidney disease/ kidney failure. Presented by experts, the first session covers the latest developments in managing lupus nephritis, ANCA vasculitis, and childhood nephrotic syndrome. The second session will highlight the impact of the COVID-19 infection on critical care nephrology, dialysis patients, and transplant recipients. The last session will elaborate on the effects of malnutrition in kidney patients, the importance of CKD of unknown etiology, and the challenges of managing CKD in developing counties.

Halim Gafor (Moderator)


Anna Burgner (Moderator)


Ikechi Okpechi (Moderator)


Daniel Tak Mao Chan

Hong Kong

David Jayne


Mignon McCulloch

South Africa

Maria Jose Soler Romeo


Manisha Sahay


Magdalena Madero



Advances in Therapy: Glomerulonephritis
Open to view video.
Open to view video. To highlight new advances in the pathogenesis and treatment of lupus nephritis. To describe the role of newer agents and their mechanisms of action in ANCA vasculitis. To improve our understanding on the pathogenic mechanisms of childhood nephrotic syndrome and available options of treatment.
Lessons Learned From Covid-19
Open to view video.
Open to view video. The COVID-19 pandemic has challenged all aspects of kidney care and led to numerous lessons learned in the field of nephrology spanning from mechanisms of acute kidney injury to the care of dialysis patients and kidney transplant patients. Learning these lessons will help us be better prepared to care kidney patients during pandemics of the future.
Overview: CKD/Kidney Failure
Open to view video.
Open to view video. Chronic kidney disease (CKD) is a rising public health problem with alarming increasing trend and high prevalence globally. Proper CKD care is very important to prolong the longevity of the functioning kidneys and to delay the progression into the costly kidney failure (KF). CKD and KF are associated with significant impact on the morbidity and mortality.